Discussion: CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression

Affiliations

Comment

Rachel A Sabol et al. Plast Reconstr Surg. 2019 Mar.

. 2019 Mar;143(3):757-758.

doi: 10.1097/PRS.0000000000005391.

¹ From the Center for Stem Cell Research and Regenerative Medicine; and the Department of Pharmacology, Tulane University School of Medicine.

No abstract available

Comment on

CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression.
Zhao R, Kaakati R, Liu X, Xu L, Lee AK, Bachelder R, Li CY, Hollenbeck ST. Zhao R, et al. Plast Reconstr Surg. 2019 Mar;143(3):747-756. doi: 10.1097/PRS.0000000000005316. Plast Reconstr Surg. 2019. PMID: 30817646 Free PMC article.

1. Zhao R, Kaakati R, Liu X, et al. CRISPR/Cas9-mediated BRCA1 knockdown adipose stem cells promote breast cancer progression Plast Reconstr Surg. 2019;143:747–756.
1. Okuma HS, Yonemori K. BRCA gene mutations and poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Adv Exp Med Biol. 2017;1026:271–286.
1. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–1948.
1. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–4434.
1. Cetin I, Topcul M. Triple negative breast cancer. Asian Pac J Cancer Prev. 2014;15:2427–2431.